First-Year Visual Acuity Outcomes of Providing Aflibercept According to the VIEW Study Protocol for Age-Related Macular Degeneration.

Saved in:
Bibliographic Details
Title: First-Year Visual Acuity Outcomes of Providing Aflibercept According to the VIEW Study Protocol for Age-Related Macular Degeneration.
Authors: Talks JS; Newcastle Upon Tyne Hospitals Foundation NHS Trust, Newcastle-upon-Tyne, United Kingdom. Electronic address: james.talks@nuth.nhs.uk., Lotery AJ; Faculty of Medicine, University of Southampton, Southamptom, United Kingdom., Ghanchi F; Bradford Teaching Hospitals, Bradford, United Kingdom., Sivaprasad S; Kings College Hospital NHS Foundation Trust, London, United Kingdom., Johnston RL; Gloucestershire Hospitals NHS Foundation Trust, United Kingdom., Patel N; East Kent Hospitals University NHS Foundation Trust, United Kingdom., McKibbin M; Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom., Bailey C; University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom., Mahmood S; Manchester Royal Eye Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom.
Corporate Authors: United Kingdom Aflibercept Users Group
Source: Ophthalmology [Ophthalmology] 2016 Feb; Vol. 123 (2), pp. 337-343. Date of Electronic Publication: 2015 Nov 12.
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7802443 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-4713 (Electronic) Linking ISSN: 01616420 NLM ISO Abbreviation: Ophthalmology Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1549-4713
DOI:10.1016/j.ophtha.2015.09.039